Photo of Mike Carey
R United States House · District 15 · Ohio On the 2026 ballot

Rep. Mike Carey

Compare
Total votes
2,501
all sessions
Attendance
99%
19 missed
Higher than 75% of chamber peers
With party
94%
of cast votes
Near the chamber average
Bipartisan score
3%
crosses aisle rarely
Near the chamber average
Sponsored
710
bills & resolutions
Near the chamber average
Committees
7
assignments
710 bills and resolutions

Sponsored bills

Total
710
Primary
62
Co-sponsor
648
This page
710
matching current filters
Co-sponsor HRES 1552
In committee · North Carolina House · Co-sponsor
Supporting the designation of the week of September 20 through September 26, 2026, as "Gold Star Families Remembrance Week".

Maddy summaryThis House resolution supports designating the week of September 20 through September 26, 2026, as "Gold Star Families Remembrance Week." It aims to honor the families of service members and veterans who have died in the line of duty. The bill encourages Americans to observe this annual week by performing acts of community service and celebrating the lives of those who made the ultimate sacrifice.

In committee Sep 16, 2026 1 co-sponsor
Co-sponsor HR 10357
In committee · North Carolina House · Co-sponsor
Digital Asset Tax Certainty Act

Maddy summaryThe Digital Asset Tax Certainty Act amends the Internal Revenue Code to clarify how cryptocurrency and other digital assets are taxed, creating a framework that treats them more like traditional financial securities for many purposes. Key provisions include allowing taxpayers to ignore small transaction fees under $10, offering simplified annual accounting methods for widely traded cryptocurrencies, and treating U.S. dollar stablecoins as cash for tax basis calculations. The bill also extends existing anti-abuse rules, such as wash sale restrictions, to digital assets and establishes a voluntary disclosure program that allows individuals to correct past reporting errors in exchange for reduced penalties. These changes aim to reduce compliance burdens for individual investors while ensuring that professional traders and dealers face tax obligations similar to those in the traditional stock market.

In committee Sep 16, 2026 1 co-sponsor
Co-sponsor HR 8957
In committee · North Carolina House · Co-sponsor
American Reserve Modernization Act of 2026

Maddy summaryThe American Reserve Modernization Act of 2026 directs the U.S. Treasury to create two new accounts: a Strategic Bitcoin Reserve for Bitcoin acquired through government forfeiture and a Digital Asset Stockpile for other digital assets. The bill mandates that all Bitcoin held in the reserve be kept for at least 20 years, with strict rules against selling or disposing of these assets during that time. It also establishes a transparency system requiring quarterly public reports and third-party audits to verify the government's holdings and management of these digital assets.

In committee Sep 16, 2026 1 co-sponsor
Co-sponsor HR 6130
In committee · North Carolina House · Co-sponsor
ASAP Act

Maddy summaryThis bill would require Medicare to cover early detection screening tests for Alzheimer's disease and related dementias starting January 1, 2028. It defines eligible tests as FDA-cleared genomic blood tests, blood product analyses, or equivalent medical imaging methods (like protein expression or whole genome sequencing) that detect pre-symptomatic or early-stage conditions. Medicare beneficiaries would receive this coverage without cost-sharing for these specific screenings. The bill amends Medicare coverage rules to explicitly include these tests under Section 1861(nnn) of the Social Security Act.

In committee Sep 16, 2026 1 co-sponsor
Co-sponsor HR 4464
In committee · North Carolina House · Co-sponsor
Preventive Health Savings Act

Maddy summaryThis bill requires the Congressional Budget Office (CBO) to identify potential budget savings from preventive health care in its scoring of proposed legislation. Specifically, it directs the CBO Director to describe and estimate reductions in future federal spending resulting from preventive health interventions - such as screenings or vaccinations - when requested by congressional budget committee leaders. These savings would be included as supplementary information in budget projections, but not used to meet budget enforcement rules. The bill does not change actual health programs or funding; it only modifies how the CBO accounts for potential long-term savings from preventive care in budget analysis.

In committee Sep 16, 2026 1 co-sponsor
Co-sponsor HR 4093
In committee · North Carolina House · Co-sponsor
Apples to Apples Comparison Act of 2025

Maddy summaryThe Apples to Apples Comparison Act of 2025 requires the Centers for Medicare & Medicaid Services (CMS) to publish detailed Medicare spending data starting in 2025. It mandates that CMS release machine-readable, county- and Metropolitan Statistical Area-level expenditure information for over 30 distinct beneficiary categories (e.g., Part A-only enrollees, Medicare Advantage members, and those with supplemental coverage) on its public website. The law also requires the Medicare Payment Advisory Commission (MedPAC) to analyze Medicare Advantage vs. traditional Medicare spending patterns beginning in 2026, with public methodology and data transparency. Additionally, the Medicare Trustees must include disaggregated expenditure data in their annual reports starting in 2026. This bill directly affects how CMS and federal agencies collect and share Medicare spending data, not beneficiaries' coverage or costs.

In committee Sep 16, 2026 1 co-sponsor
Co-sponsor HR 1266
Passed · North Carolina House · Co-sponsor
Combating Illicit Xylazine Act

Maddy summaryHR 1266, the Combating Illicit Xylazine Act, adds xylazine - a veterinary sedative increasingly found in illicit drug mixtures - to Schedule III of the Controlled Substances Act, regulating its use and trafficking. It directly affects veterinarians, animal owners, and manufacturers by allowing xylazine to be legally dispensed for animal use under specific veterinary prescriptions, while prohibiting non-veterinary human use. The bill includes transition periods (60 days for practitioners, 1 year for labeling) to ease compliance for manufacturers and practitioners, and requires the DEA and FDA to expedite necessary applications. It also mandates two congressional reports on xylazine's illicit use and trafficking patterns, and directs the Sentencing Commission to review penalties for offenses involving xylazine.

Passed Sep 16, 2026 1 co-sponsor
Showing 1 to 10 of 710 bills
1 2 3 … 71 Next